Search research articles
Contact Us
Filters
Showing results (51-60 of 106) with videos related to
Page
of 11
Sort By:
The Journal of Infectious Diseases
|
January 15, 2004
Strong cell-mediated immune responses are associated with the maintenance of low-level viremia in antiretroviral-treated individuals with drug-resistant human immunodeficiency virus type 1
Steven G Deeks, Jeffrey N Martin, Elizabeth Sinclair, et al.
Journal of Virology
|
August 21, 2025
Parallel evolution of the elite neutralizer phenotype in divergent HIV-1 clades
Kathryn A Mesa, Sophia W Li, Jennie M Hutchinson, et al.
Journal of Virology
|
November 16, 2004
Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies
James M Binley, Terri Wrin, Bette Korber, et al.
Journal of Virology
|
August 10, 2007
Adjunctive passive immunotherapy in human immunodeficiency virus type 1-infected individuals treated with antiviral therapy during acute and early infection
Saurabh Mehandru, Brigitta Vcelar, Terri Wrin, et al.
Virology
|
October 26, 2005
Analysis of HIV-1 subtype B third variable region peptide motifs for induction of neutralizing antibodies against HIV-1 primary isolates
Barton F Haynes, Benjiang Ma, David C Montefiori, et al.
Journal of Virology
|
March 30, 2007
Macaques infected with a CCR5-tropic simian/human immunodeficiency virus (SHIV) develop broadly reactive anti-HIV neutralizing antibodies
Zane Kraft, Nina R Derby, Ruth A McCaffrey, et al.
Plos One
|
April 11, 2019
Ancestral sequences from an elite neutralizer proximal to the development of neutralization resistance as a potential source of HIV vaccine immunogens
Kathryn A Mesa, Bin Yu, Terri Wrin, et al.
The Journal of Infectious Diseases
|
July 9, 2010
Magnitude and breadth of a nonprotective neutralizing antibody response in an efficacy trial of a candidate HIV-1 gp120 vaccine
Peter Gilbert, Maggie Wang, Terri Wrin, et al.
AIDS Research and Human Retroviruses
|
August 15, 2009
Characterization of human immunodeficiency virus type 1 populations containing CXCR4-using variants from recently infected individuals
Wei Huang, Jonathan Toma, Eric Stawiski, et al.
Virology
|
September 12, 2006
Lack of neutralizing antibody response to HIV-1 predisposes to superinfection
Davey M Smith, Matthew C Strain, Simon D W Frost, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 106) with videos related to
Sort By:
Page
of 11
The Journal of Infectious Diseases
|
January 15, 2004
Strong cell-mediated immune responses are associated with the maintenance of low-level viremia in antiretroviral-treated individuals with drug-resistant human immunodeficiency virus type 1
Steven G Deeks, Jeffrey N Martin, Elizabeth Sinclair, et al.
Journal of Virology
|
August 21, 2025
Parallel evolution of the elite neutralizer phenotype in divergent HIV-1 clades
Kathryn A Mesa, Sophia W Li, Jennie M Hutchinson, et al.
Journal of Virology
|
November 16, 2004
Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies
James M Binley, Terri Wrin, Bette Korber, et al.
Journal of Virology
|
August 10, 2007
Adjunctive passive immunotherapy in human immunodeficiency virus type 1-infected individuals treated with antiviral therapy during acute and early infection
Saurabh Mehandru, Brigitta Vcelar, Terri Wrin, et al.
Virology
|
October 26, 2005
Analysis of HIV-1 subtype B third variable region peptide motifs for induction of neutralizing antibodies against HIV-1 primary isolates
Barton F Haynes, Benjiang Ma, David C Montefiori, et al.
Journal of Virology
|
March 30, 2007
Macaques infected with a CCR5-tropic simian/human immunodeficiency virus (SHIV) develop broadly reactive anti-HIV neutralizing antibodies
Zane Kraft, Nina R Derby, Ruth A McCaffrey, et al.
Plos One
|
April 11, 2019
Ancestral sequences from an elite neutralizer proximal to the development of neutralization resistance as a potential source of HIV vaccine immunogens
Kathryn A Mesa, Bin Yu, Terri Wrin, et al.
The Journal of Infectious Diseases
|
July 9, 2010
Magnitude and breadth of a nonprotective neutralizing antibody response in an efficacy trial of a candidate HIV-1 gp120 vaccine
Peter Gilbert, Maggie Wang, Terri Wrin, et al.
AIDS Research and Human Retroviruses
|
August 15, 2009
Characterization of human immunodeficiency virus type 1 populations containing CXCR4-using variants from recently infected individuals
Wei Huang, Jonathan Toma, Eric Stawiski, et al.
Virology
|
September 12, 2006
Lack of neutralizing antibody response to HIV-1 predisposes to superinfection
Davey M Smith, Matthew C Strain, Simon D W Frost, et al.
Page
of 11